PROG News and Press, Progenity Inc. From 01/25/22

SAN DIEGO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the award of another new patent related to its single-molecule detection assay platform under development. The USPTO has issued U.S. Patent No. 11,230,731 en...

Today we look at a handful of penny stocks gaining a lot of attention on social media. One of the most significant driving forces since the start of the 2020 pandemic has been droves of new retail traders pumping liquidity into the market. There are a few different schools of thought ab...

4 Penny Stocks to Add to Your Watchlist Right Now After a more than shaky week of trading for both penny stocks and blue chips, investors are excited to get another week up and going. But, to make money with penny stocks , traders need to do two things. First and foremost, investors...

Are you looking for penny stocks to buy right now? You’re not alone, and the latest resurgence in retail trading trends has placed a focus back on meme stocks. Some may call them “Reddit penny stocks,” “stonks,” or give various other titles. Let’s c...

SAN DIEGO, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that patient data on indicators of efficacy in the treatment of gastrointestinal d...

SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that two presentations with patient data on indicators of efficacy in the treatmen...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips For folks who like to take a chance on biotechnology businesses, California-headquartered Progenity  (NASDAQ: PROG ) offers upside potential at an affordable price point. Indeed, PROG stock’s appeal is that...

SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that the company will participate in a pre-recorded presentation at the H.C. Wainw...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Progenity (NASDAQ: PROG ) is a clinical-stage biotech company. PROG stock completed its initial public offering (IPO) in 2020 at $15 per share. Source: Mongkolchon Akesin / Shutterstock.com The company would suf...

Progenity is transitioning away from molecular testing operations to focus on the development of biotherapeutics. In this respect, the third quarter's financials were pivotal to the transformation strategy as it translated into a reduction in operational expenses as planned. With ...